OLAPARIB

OLAPARIB CAPSULES 50 / 150 MG

Indication

Olaparib is indicated as monotherapy for the Maintenance treatment of adult patients with germline BRCA-mutated metastatic adenocarcinoma of the pancreas whose disease has not progressed on first-line platinum-based chemotherapy.

Pack

112 / 120 Capsules
Categories: ,

Note: Products are not marketed in countries where it is protected by Patent Law